{"uid":"urn:va:document:F484:100847:4428","summary":"ATTENDING NOTE  ","pid":"0000000346","author":"AVIVAUSER,SEVEN","authorDisplayName":"Avivauser,Seven","signer":"AVIVAUSER,SEVEN","signedDateTime":"02/21/13 16:58","entered":"20130221113904","kind":"Progress Note","text":[{"uid":"urn:va:document:F484:100847:4428","summary":"gov.va.cpe.vpr.DocumentText@1be41c0","clinicians":[{"uid":"urn:va:user:F484:1091","summary":"gov.va.cpe.vpr.DocumentClinician@9a7911","name":"AVIVAUSER,SEVEN","displayName":"Avivauser,Seven","role":"A"},{"uid":"urn:va:user:F484:1091","summary":"gov.va.cpe.vpr.DocumentClinician@1825ee3","name":"AVIVAUSER,SEVEN","displayName":"Avivauser,Seven","role":"S","signedDateTime":"20130221165837","signature":"SEVEN AVIVAUSER "}],"content":"SIGNIFICANT ISSUES/SYMPTOMS/PROBLEMS: \r\n\r\nThe patient is doing much better.  Her SI is now passive and she has no \r\nsuicide plans.  She is feeling more hopeful that things will improve over \r\ntime. Her husband's job is okay now.  She is appreciative of medical staff \r\nand her family that is supporting her well.\r\n\r\n\r\nPROBLEM LIST:\r\nComputerized Problem List is the source for the following: \r\n \r\n1. Obesity, Onset 00/00/04                            05/30/12 \r\nAVIVAUSER,THIRT\r\n2. Hyperlipidemia                                     09/22/09  PROVIDER,ONE \r\n3. Diabetes Mellitus Type II or unspecified, Onset    05/10/12  PROVIDER,ONE \r\n00/00/05 \r\n     Adequate control on oral medications.\r\n     Goal to lose 50 pounds in 1 year.\r\n4. Osteopenia, Onset 00/00/08                         11/19/08  PROVIDER,ONE \r\n5. Postsurgical hypothyroidism, Onset 00/00/02        05/10/12  PROVIDER,ONE \r\n     Complete thryoidectomy for thyroid cancer in 2002.\r\n6. Depression, Onset 00/00/08                         11/19/08  PROVIDER,ONE \r\n7. Hypertension, Onset 00/00/05                       11/09/08  PROVIDER,ONE \r\n\r\n\r\nActive Inpatient Medications (excluding Supplies):\r\n \r\n     Active Inpatient Medications                           Status\r\n=========================================================================\r\n1)   ASPIRIN TAB,EC  81MG PO QDAY                           ACTIVE\r\n2)   CALCIUM CARBONATE TAB  500 MG PO TID                   ACTIVE\r\n3)   CHLORTHALIDONE TAB  12.5 MG PO QDAY                    ACTIVE\r\n4)   ERGOCALCIFEROL CAP,ORAL  1000 UNITS PO QDAY            ACTIVE\r\n5)   GLYBURIDE TAB  2.5MG PO QDAY                           ACTIVE\r\n6)   LEVOTHYROXINE NA (SYNTHROID) TAB  0.125MG PO QDAY      ACTIVE\r\n7)   LISINOPRIL TAB  20MG PO QDAY                           ACTIVE\r\n8)   SIMVASTATIN TAB  80MG PO QPM                           ACTIVE\r\n9)   VENLAFAXINE TAB  75MG PO BID                           ACTIVE\r\n\r\nRELEVANT MENTAL STATUS AND OTHER OBJECTIVE FINDINGS:\r\n depressed mood,  blunted affect,     Still quite sad.  Crying during a \r\nportion \r\nof our encounter.\r\n\r\nVITAL SIGNS:\r\n            B/P:  138/89 (02/19/2013 07:30)\r\n          Pulse:  98 (02/19/2013 07:30)\r\n    Temperature:  99.1 F [37.3 C] (02/19/2013 07:30)\r\n   Respirations:  20 (02/19/2013 07:30)\r\n         Weight:  241 lb [109.5 kg] (11/20/2012 16:31)\r\n         Height:  64 in [162.6 cm] (11/20/2012 16:31)\r\n            BMI:  41\r\n           Pain:  0 (02/19/2013 07:30)\r\n\r\nHISTORY OF SUICIDAL ACTS AND SELF-HARM: \r\nNone\r\n\r\nHISTORY OF VIOLENCE/ASSAULTING OTHERS/LEGAL PROBLEMS:\r\nNone\r\n\r\nSUBSTANCE USE HISTORY: \r\nNone\r\n\r\nMENTAL ILLNESS AND SUBSTANCE ABUSE IN FAMILY MEMBERS: \r\nNone\r\n\r\nPSYCHOSOCIAL HISTORY: \r\n a) Childhood/Developmental History: \r\n\r\n b) Adult Relationship History: \r\n\r\n c) Current significant family and/or peer group relationships: \r\n\r\n\r\n d) Financial Status, Housing, Employment, Leisure Time Issues: \r\n\r\n e) Religious/Spiritual or Cultural Issues that might influence treatment: \r\nNone\r\n\r\n f) Relevant community resources accessed by patient:\r\n \r\nALLERGIES AND ADVERSE DRUG REACTIONS: \r\nMETFORMIN, CITALOPRAM, FLUOXETINE\r\n\r\n \r\nMENTAL STATUS EXAM:\r\n-------------------\r\nORIENTATION AND CONSCIOUSNESS:\r\n  alert and attentive\r\n  oriented x3\r\nAPPEARANCE AND BEHAVIOR:\r\n  cooperative and reasonable\r\n  grooming appropriate\r\nSPEECH:\r\n  normal rate/rhythm\r\nLANGUAGE:\r\n  intact\r\nMOOD AND AFFECT:\r\n  mood euthymic\r\n  affect is congruent with mood\r\nPERCEPTUAL DISTURBANCE (hallucinations, illusions):\r\n  none\r\nTHOUGHT PROCESS AND ASSOCIATION:\r\n  normal, coherent\r\nTHOUGHT CONTENT (delusions, obsessions etc.):\r\n  details:  passive SI\r\nSUICIDAL OR VIOLENT IDEATION:\r\n  suicidal ideation passive without plan, contracts for safety\r\nINSIGHT:\r\n  good\r\nJUDGMENT: \r\n  good\r\nMEMORY: \r\n  intact\r\nFUND OF KNOWLEDGE\r\n    Average\r\nASSESSMENT OF DANGER TO SELF:\r\n--------------------------------------\r\nSUICIDE RISK CHECKLIST:\r\n  Suicide ideation\r\nPROTECTIVE FACTORS:\r\n  Evidence of accessible and positively motivated social supports, \r\nTherapeutic \r\nalliance with a mental health professional\r\nASSESSMENT OF DANGER TO OTHERS:\r\n-------------------------------------\r\nNo significant risk.\r\n                      INITIAL DSM-IV DIAGNOSIS:\r\nAxis I Clinical Disorder:\r\n  Depressive Disorder:  Major Depression\r\nAxis II Personality Disorders/Traits:\r\n  None\r\nAxis III Current Medical Conditions:  See Medical History above\r\nAxis IV Current Psychosocial Stressors:\r\nNone \r\n \r\nAxis V GAF Score (current level of functioning): 40\r\n\r\n \r\n Patient Health Questionnaire - 9 (PHQ-9)\r\n \r\n Date Given: 02/19/2013\r\n Clinician: Avivauser,Seven\r\n Location: Psychiatry\r\n \r\n Veteran: Avivapatient, Six\r\n SSN: xxx-xx-0926\r\n DOB: Feb 2,1957 (56)\r\n Gender: Female\r\n \r\n    PHQ-9 Depression Scale Score: 14\r\n \r\n Guide for Interpreting PHQ-9 scores:\r\n   0-4: The score suggests the patient may not need depression treatment.\r\n   5-14: Physician uses clinical judgment about treatment based on \r\n             patient's duration of symptoms and functional impairment.\r\n   15 or more: Warrants treatment for depression, using antidepressant, \r\n             psychotherapy and/or a combination of treatment.\r\n \r\n Questions and Answers\r\n \r\n Over the last 2 weeks, how often have you been bothered by any of the \r\nfollowing problems?\r\n 1. Little interest or pleasure in doing things\r\n     Several days\r\n 2. Feeling down, depressed, or hopeless\r\n     Nearly every day\r\n 3. Trouble falling or staying asleep, or sleeping too much\r\n     More than half the days\r\n 4. Feeling tired or having little energy\r\n     Several days\r\n 5. Poor appetite or overeating\r\n     Several days\r\n 6. Feeling bad about yourself or that you are a failure or have let yourself \r\nor your family down\r\n     Several days\r\n 7. Trouble concentrating on things, such as reading the newspaper or watching \r\ntelevision\r\n     More than half the days\r\n 8. Moving or speaking so slowly that other people could have noticed. Or the \r\nopposite being so fidgety or restless that you have been moving around a lot \r\nmore than usual\r\n     Several days\r\n 9. Thoughts that you would be better off dead or of hurting yourself in some \r\nway\r\n     More than half the days\r\n 10. If you checked off any problems, how DIFFICULT have these problems made it \r\nfor you to do your work, take care of things at home or get along with other \r\npeople?\r\n     Very difficult\r\n \r\n Information contained in this note is based on a self report assessment and is \r\nnot sufficient to use alone for diagnostic purposes. Assessment results should \r\nbe verified for accuracy and used in conjunction with other diagnostic \r\nactivities.\r\n \r\n Copyright 2001 Pfizer Inc.\r\n All rights reserved. Reproduced with permission of Pfizer Inc.\r\n PRIME-MD is a trademark of Pfizer Inc \r\n\r\n\r\nASSESSMENT:\r\nMuch improved.  Some passive SI persists.\r\n\r\nPLAN:\r\nContinue current management; possible discharge tomorrow.\r\n","dateTime":"201302191138","status":"completed","author":"AVIVAUSER,SEVEN","authorDisplayName":"Avivauser,Seven"}],"facilityCode":"500D","facilityName":"SLC-FO HMP DEV","localId":"4428","encounterUid":"urn:va:visit:F484:100847:7595","encounterName":"PSYCHIATRY Feb 15, 2013","referenceDateTime":"201302191138","documentTypeCode":"PN","documentTypeName":"Progress Note","documentClass":"PROGRESS NOTES","localTitle":"ATTENDING NOTE  ","nationalTitle":{"title":"ATTENDING NOTE","vuid":"urn:va:vuid:4693479"},"clinicians":[{"uid":"urn:va:user:F484:1091","summary":"gov.va.cpe.vpr.DocumentClinician@9a7911","name":"AVIVAUSER,SEVEN","displayName":"Avivauser,Seven","role":"A"},{"uid":"urn:va:user:F484:1091","summary":"gov.va.cpe.vpr.DocumentClinician@1825ee3","name":"AVIVAUSER,SEVEN","displayName":"Avivauser,Seven","role":"S","signedDateTime":"20130221165837","signature":"SEVEN AVIVAUSER "}],"statusName":"completed","nationalTitleRole":{"role":"ATTENDING","vuid":"urn:va:vuid:4696128"},"nationalTitleType":{"type":"NOTE","vuid":"urn:va:vuid:4696120"}}